Divi's Laboratories (NSE:DIVISLAB) Accumulated Depreciation: ₹-28,550 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:DIVISLAB Divi's Laboratories Ltd NSE:DIVISLAB
93 GF Score
Price ₹8,585.00
GF Value ₹6,806.33
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Divi's Laboratories Accumulated Depreciation?

Divi's Laboratories NSE:DIVISLAB +6.57% 93 Accumulated Depreciation is ₹-28,550 Mil as of Mar. 2026. GuruFocus rates NSE:DIVISLAB with a GF Score™ of 93/100 and a GF Value™ of ₹6,806.33 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Divi's Laboratories's quarterly accumulated depreciation stayed the same from Sep. 2025 (₹0 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹-28,550 Mil).

Divi's Laboratories's annual accumulated depreciation increased from Mar. 2024 (₹-19,960 Mil) to Mar. 2025 (₹-23,980 Mil) and increased from Mar. 2025 (₹-23,980 Mil) to Mar. 2026 (₹-28,550 Mil).

Divi's Laboratories Accumulated Depreciation Related Terms

Divi's Laboratories Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Divi's Laboratories's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Divi's Laboratories Accumulated Depreciation Chart

Divi's Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12,815.20 -16,210.00 -19,960.00 -23,980.00 -28,550.00

Divi's Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23,980.00 0.00 0.00 0.00 -28,550.00
NSE:DIVISLAB
93GF Score
Divi's Laboratories Ltd NSE:DIVISLAB
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Divi's Laboratories Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of ₹-28,550 Mil mean?
Divi's Laboratories (NSE:DIVISLAB) has a Accumulated Depreciation of ₹-28,550 Mil as of Mar. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Divi's Laboratories and its competitors.
Is Divi's Laboratories' Accumulated Depreciation too high?
Divi's Laboratories' current Accumulated Depreciation is ₹-28,550 Mil. Overall, Divi's Laboratories has a GF Score™ of 93/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Divi's Laboratories' Accumulated Depreciation compare to ZTS?
Divi's Laboratories' Accumulated Depreciation of ₹-28,550 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Drug Manufacturers company?
A good Accumulated Depreciation depends on the Drug Manufacturers industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Divi's Laboratories and its competitors. Divi's Laboratories's current Accumulated Depreciation is ₹-28,550 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Divi's Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Divi's Laboratories (NSE:DIVISLAB) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹6,806.33, compared to a current price of ₹8,585.00 — trading 26.1% above its estimated fair value. The current Accumulated Depreciation is ₹-28,550 Mil. Divi's Laboratories' overall GF Score™ is 93/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Divi's Laboratories (NSE:DIVISLAB), the current Accumulated Depreciation is ₹-28,550 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Divi's Laboratories (NSE:DIVISLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Divi's Laboratories stock appears to be overvalued. The current stock price of ₹8,585.00 is trading 26.1% above its estimated GF Value™ of ₹6,806.33. GuruFocus considers Divi's Laboratories to be Modestly Overvalued.

Key valuation signals for NSE:DIVISLAB:

  • Accumulated Depreciation: ₹-28,550 Mil
  • GF Value™: ₹6,806.33 vs. price of ₹8,585.00 (26.1% above fair value)
  • GF Score™: 93/100 with 7 warning signs

No single metric tells the full story. See the NSE:DIVISLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Divi's Laboratories Business Description

Other Exchanges 532488:India
Address Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients, with a predominance in exports. It also, through its custom synthesis, supports pharma companies for their patented products business from gram-scale requirements for clinical trials to launch, as well as late-life cycle management. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world.
93GF Score

Get the complete analysis for NSE:DIVISLAB

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹8,585.00
Price
₹6,806.33
GF Value